Long Non-coding RNA ARAP1-AS1 Accelerates Cell Proliferation and Migration in Breast Cancer Through MiR-2110/HDAC2/PLIN1 Axis

Overview

Journal Biosci Rep

Specialty Cell Biology

Date 2020 Feb 29

PMID 32110804

Citations 15

Authors

Chong Lu

Xiuhua Wang

Xiangwang Zhao

Yue Xin

Chunping Liu

Affiliations

Soon will be listed here.

Abstract

Breast cancer (BC) poses a great threaten to women health. Numerous evidences suggest the important role of long non-coding RNAs (lncRNAs) in BC development. In the present study, we intended to investigate the role of ARAP1-AS1 in BC progression. First of all, the GEPIA data suggested that ARAP1-AS1 was highly expressed in breast invasive carcinoma (BRAC) tissues compared with the normal breast tissues. Meanwhile, the expression of ARAP1-AS1 was greatly up-regulated in BC cell lines. ARAP1-AS1 knockdown led to repressed proliferation, strengthened apoptosis and blocked migration of BC cells. Moreover, ARAP1-AS1 could boost HDAC2 expression in BC through sponging miR-2110 via a ceRNA mechanism. Of note, the UCSC predicted that HDAC2 was a potential transcriptional regulator of PLIN1, an identified tumor suppressor in BC progression. Moreover, we explained that the repression of HDAC2 on PLIN1 was owing to its deacetylation on PLIN1 promoter. More importantly, depletion of PLIN1 attenuated the mitigation function of ARAP1-AS1 silence on the malignant phenotypes of BC cells. To sum up, ARAP1-AS1 serves a tumor-promoter in BC development through modulating miR-2110/HDAC2/PLIN1 axis, which may help to develop novel effective targets for BC treatment.

Citing Articles

Aberrant expression of GTPase-activating protein ARAP1 triggers circular dorsal ruffles associated with malignancy in hepatocellular carcinoma Hep3B cells.

Sun X, Li Y, He Y, Cheng L, Wang L, Wei J Cell Commun Signal. 2025; 23(1):75.

PMID: 39934854 PMC: 11816549. DOI: 10.1186/s12964-025-02084-4.

PLIN1 suppresses glioma progression through regulating lipid metabolism.

Luo K, Zhuang K, Wu H, Chen Y, Liu Y, Yang F Cell Death Dis. 2025; 16(1):48.

PMID: 39870645 PMC: 11772837. DOI: 10.1038/s41419-025-07347-z.

Emerging roles of interactions between ncRNAs and other epigenetic modifications in breast cancer.

Xie J, Gan L, Xue B, Wang X, Pei X Front Oncol. 2023; 13:1264090.

PMID: 37901333 PMC: 10602744. DOI: 10.3389/fonc.2023.1264090.

Mutual Regulation of ncRNAs and Chromatin Remodeling Complexes in Normal and Pathological Conditions.

Bure I, Nemtsova M Int J Mol Sci. 2023; 24(9).

PMID: 37175555 PMC: 10178202. DOI: 10.3390/ijms24097848.

Adding fuel to the fire: The lipid droplet and its associated proteins in cancer progression.

Luo W, Wang H, Ren L, Lu Z, Zheng Q, Ding L Int J Biol Sci. 2022; 18(16):6020-6034.

PMID: 36439875 PMC: 9682530. DOI: 10.7150/ijbs.74902.

References

Tay Y, Rinn J, Pandolfi P . The multilayered complexity of ceRNA crosstalk and competition. Nature. 2014; 505(7483):344-52. PMC: 4113481. DOI: 10.1038/nature12986. View

Holmes C, Muss H . Diagnosis and treatment of breast cancer in the elderly. CA Cancer J Clin. 2003; 53(4):227-44. DOI: 10.3322/canjclin.53.4.227. View

Malvia S, Bagadi S, Pradhan D, Chintamani C, Bhatnagar A, Arora D . Study of Gene Expression Profiles of Breast Cancers in Indian Women. Sci Rep. 2019; 9(1):10018. PMC: 6620270. DOI: 10.1038/s41598-019-46261-1. View

Niknafs Y, Han S, Ma T, Speers C, Zhang C, Wilder-Romans K . The lncRNA landscape of breast cancer reveals a role for DSCAM-AS1 in breast cancer progression. Nat Commun. 2016; 7:12791. PMC: 5052669. DOI: 10.1038/ncomms12791. View

Zheng B, Han M, Shu Y, Li Y, Miao S, Zhang X . HDAC2 phosphorylation-dependent Klf5 deacetylation and RARα acetylation induced by RAR agonist switch the transcription regulatory programs of p21 in VSMCs. Cell Res. 2011; 21(10):1487-508. PMC: 3193446. DOI: 10.1038/cr.2011.34. View

Liu M, Zhang Q, Yuan X, Jin L, Wang L, Fang T . Long noncoding RNA RP4 functions as a competing endogenous RNA through miR-7-5p sponge activity in colorectal cancer. World J Gastroenterol. 2018; 24(9):1004-1012. PMC: 5840465. DOI: 10.3748/wjg.v24.i9.1004. View

Kim J, Piao H, Kim B, Yao F, Han Z, Wang Y . Long noncoding RNA MALAT1 suppresses breast cancer metastasis. Nat Genet. 2018; 50(12):1705-1715. PMC: 6265076. DOI: 10.1038/s41588-018-0252-3. View

Li J, Liu S, Zhou H, Qu L, Yang J . starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2013; 42(Database issue):D92-7. PMC: 3964941. DOI: 10.1093/nar/gkt1248. View

Anastasiadou E, Jacob L, Slack F . Non-coding RNA networks in cancer. Nat Rev Cancer. 2017; 18(1):5-18. PMC: 6337726. DOI: 10.1038/nrc.2017.99. View

10.

Pan J, Li X, Wu W, Xue M, Hou H, Zhai W . Long non-coding RNA UCA1 promotes cisplatin/gemcitabine resistance through CREB modulating miR-196a-5p in bladder cancer cells. Cancer Lett. 2016; 382(1):64-76. DOI: 10.1016/j.canlet.2016.08.015. View

11.

Paraskevopoulou M, Vlachos I, Karagkouni D, Georgakilas G, Kanellos I, Vergoulis T . DIANA-LncBase v2: indexing microRNA targets on non-coding transcripts. Nucleic Acids Res. 2015; 44(D1):D231-8. PMC: 4702897. DOI: 10.1093/nar/gkv1270. View

12.

Chen X, Chen Z, Yu S, Nie F, Yan S, Ma P . Long Noncoding RNA LINC01234 Functions as a Competing Endogenous RNA to Regulate CBFB Expression by Sponging miR-204-5p in Gastric Cancer. Clin Cancer Res. 2018; 24(8):2002-2014. DOI: 10.1158/1078-0432.CCR-17-2376. View

13.

Kim S, Lee Y, Koo J . Differential expression of lipid metabolism-related proteins in different breast cancer subtypes. PLoS One. 2015; 10(3):e0119473. PMC: 4353724. DOI: 10.1371/journal.pone.0119473. View

14.

Zhao H, Yu Z, Zhao L, He M, Ren J, Wu H . HDAC2 overexpression is a poor prognostic factor of breast cancer patients with increased multidrug resistance-associated protein expression who received anthracyclines therapy. Jpn J Clin Oncol. 2016; 46(10):893-902. DOI: 10.1093/jjco/hyw096. View

15.

Prensner J, Chinnaiyan A . The emergence of lncRNAs in cancer biology. Cancer Discov. 2011; 1(5):391-407. PMC: 3215093. DOI: 10.1158/2159-8290.CD-11-0209. View

16.

Wahlestedt C . Targeting long non-coding RNA to therapeutically upregulate gene expression. Nat Rev Drug Discov. 2013; 12(6):433-46. DOI: 10.1038/nrd4018. View

17.

Ye Y, Gu B, Wang Y, Shen S, Huang W . YY1-Induced Upregulation of Long Noncoding RNA ARAP1-AS1 Promotes Cell Migration and Invasion in Colorectal Cancer Through the Wnt/β-Catenin Signaling Pathway. Cancer Biother Radiopharm. 2019; 34(8):519-528. DOI: 10.1089/cbr.2018.2745. View

18.

Yamakawa H, Cheng J, Penney J, Gao F, Rueda R, Wang J . The Transcription Factor Sp3 Cooperates with HDAC2 to Regulate Synaptic Function and Plasticity in Neurons. Cell Rep. 2017; 20(6):1319-1334. DOI: 10.1016/j.celrep.2017.07.044. View

19.

Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z . GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017; 45(W1):W98-W102. PMC: 5570223. DOI: 10.1093/nar/gkx247. View

20.

Bonasio R, Shiekhattar R . Regulation of transcription by long noncoding RNAs. Annu Rev Genet. 2014; 48:433-55. PMC: 4285387. DOI: 10.1146/annurev-genet-120213-092323. View